Coral Laboratories Limited (CORALAB.BO)
INR 747.6
(-3.64%)
INR 747.6
(-3.64%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.05 Billion INR | 17.97% |
| 2022 | 1.74 Billion INR | -8.19% |
| 2021 | 1.89 Billion INR | 13.34% |
| 2020 | 1.67 Billion INR | 16.12% |
| 2019 | 1.44 Billion INR | 6.27% |
| 2018 | 1.35 Billion INR | -3.15% |
| 2017 | 1.4 Billion INR | 6.91% |
| 2016 | 1.31 Billion INR | 55.08% |
| 2015 | 845.51 Million INR | 16.76% |
| 2014 | 724.15 Million INR | 19.7% |
| 2013 | 604.96 Million INR | 3.87% |
| 2012 | 582.39 Million INR | 19.03% |
| 2011 | 489.28 Million INR | 17.86% |
| 2010 | 415.12 Million INR | -3.45% |
| 2009 | 429.96 Million INR | 7.44% |
| 2008 | 400.2 Million INR | -3.62% |
| 2007 | 415.25 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 2.05 Billion INR | 17.97% |
| 2023 Q4 | 2.05 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.98 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 1.74 Billion INR | 0.0% |
| 2022 FY | 1.74 Billion INR | -8.19% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 2.11 Billion INR | 0.0% |
| 2021 Q2 | 1.75 Billion INR | 0.0% |
| 2021 FY | 1.89 Billion INR | 13.34% |
| 2021 Q4 | 1.89 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 1.56 Billion INR | 0.0% |
| 2020 FY | 1.67 Billion INR | 16.12% |
| 2020 Q4 | 1.67 Billion INR | 0.0% |
| 2019 Q2 | 1.31 Billion INR | 0.0% |
| 2019 FY | 1.44 Billion INR | 6.27% |
| 2019 Q4 | 1.44 Billion INR | 0.0% |
| 2018 Q4 | 1.35 Billion INR | 0.0% |
| 2018 FY | 1.35 Billion INR | -3.15% |
| 2018 Q2 | 1.4 Billion INR | 0.0% |
| 2017 FY | 1.4 Billion INR | 6.91% |
| 2017 Q2 | 1.79 Billion INR | 0.0% |
| 2017 Q4 | 1.4 Billion INR | 0.0% |
| 2016 Q2 | 1.02 Billion INR | 0.0% |
| 2016 Q4 | 1.31 Billion INR | 0.0% |
| 2016 FY | 1.31 Billion INR | 55.08% |
| 2015 FY | 845.51 Million INR | 16.76% |
| 2015 Q4 | 845.51 Million INR | 0.0% |
| 2015 Q2 | 802.66 Million INR | 0.0% |
| 2014 Q4 | 724.15 Million INR | 0.0% |
| 2014 Q2 | 631.5 Million INR | 0.0% |
| 2014 FY | 724.15 Million INR | 19.7% |
| 2013 Q2 | 600.21 Million INR | 0.0% |
| 2013 Q4 | 604.96 Million INR | 0.0% |
| 2013 FY | 604.96 Million INR | 3.87% |
| 2012 Q4 | 582.39 Million INR | 0.0% |
| 2012 FY | 582.39 Million INR | 19.03% |
| 2011 FY | 489.28 Million INR | 17.86% |
| 2011 Q4 | 489.28 Million INR | 0.0% |
| 2010 Q4 | 415.12 Million INR | 0.0% |
| 2010 FY | 415.12 Million INR | -3.45% |
| 2009 FY | 429.96 Million INR | 7.44% |
| 2008 FY | 400.2 Million INR | -3.62% |
| 2007 FY | 415.25 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 33.74 Million INR | -5995.5% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | -105.749% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -442.481% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -451.378% |
| Sunil Healthcare Limited | 1.58 Billion INR | -29.767% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -1480.31% |
| MedPlus Health Services Limited | 30.04 Billion INR | 93.155% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | -9.029% |
| Patidar Buildcon Limited | 94.27 Million INR | -2081.685% |
| Roopa Industries Limited | 647.82 Million INR | -217.496% |
| Smruthi Organics Limited | 1.18 Billion INR | -74.024% |
| Trident Lifeline Limited | 870.76 Million INR | -136.207% |
| PANJON LTD. | 173.91 Million INR | -1082.67% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | -125.179% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -783.754% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -2062.236% |
| Anuh Pharma Limited | 4.45 Billion INR | 53.85% |
| Crestchem Limited | 71.44 Million INR | -2778.986% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -2252.543% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -292.408% |
| Tyche Industries Limited | 1.36 Billion INR | -50.242% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 33.134% |
| Trimurthi Limited | 73.64 Million INR | -2692.71% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | -164.245% |
| Norris Medicines Limited | 141.87 Million INR | -1349.75% |
| Zenlabs Ethica Limited | 402.58 Million INR | -410.901% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | -44.16% |
| ANG Lifesciences India Limited | 2.42 Billion INR | 15.161% |
| Parmax Pharma Limited | 176.12 Million INR | -1067.801% |
| Veerhealth Care Limited | 281.16 Million INR | -631.522% |
| Deccan Health Care Limited | 1.08 Billion INR | -90.36% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 27.354% |
| Makers Laboratories Limited | 1.61 Billion INR | -27.549% |
| Lactose (India) Limited | 1 Billion INR | -104.172% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | -225.485% |
| Zenith Healthcare Limited | 97.41 Million INR | -2011.428% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -373.86% |
| Bacil Pharma Limited | 13.26 Million INR | -15410.18% |
| PRAVEG LIMITED | 3.64 Billion INR | 43.586% |
| Denis Chem Lab Limited | 1.09 Billion INR | -88.096% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 47.825% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | -24.58% |
| Colinz Laboratories Limited | 113.59 Million INR | -1710.663% |
| Godavari Drugs Limited | 1.34 Billion INR | -52.636% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -11585.728% |
| Zenotech Laboratories Limited | 1.06 Billion INR | -93.661% |
| Panchsheel Organics Limited | 1.59 Billion INR | -29.314% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | -20.327% |
| Vivanza Biosciences Limited | 195.01 Million INR | -954.696% |
| Phaarmasia Limited | 314.47 Million INR | -554.038% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 82.108% |
| Medi-Caps Limited | 1.27 Billion INR | -61.591% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -511.542% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | 6.98% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 17.803% |
| Mercury Laboratories Limited | 679.57 Million INR | -202.661% |
| Gennex Laboratories Limited | 2.29 Billion INR | 10.568% |
| BDH Industries Limited | 934.11 Million INR | -120.188% |
| Concord Drugs Limited | 588.06 Million INR | -249.759% |
| Bharat Parenterals Limited | 5.03 Billion INR | 59.176% |
| Beryl Drugs Limited | 174.86 Million INR | -1076.198% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | -254.75% |
| Evoq Remedies Limited | 368.61 Million INR | -457.989% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | -63.298% |
| Transchem Limited | 763.18 Million INR | -169.505% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -1802.916% |
| Parnax Lab Limited | 1.88 Billion INR | -8.961% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -769.659% |
| Kerala Ayurveda Limited | 1.4 Billion INR | -45.979% |
| Cian Healthcare Limited | 1.61 Billion INR | -27.613% |
| Trinity League India Limited | 32.38 Million INR | -6250.908% |
| Syschem (India) Limited | 1.64 Billion INR | -25.393% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | -188.094% |
| Natural Capsules Limited | 3.76 Billion INR | 45.374% |
| Auro Laboratories Limited | 852.67 Million INR | -141.217% |